Follow-up after surgery for primary breast cancer;Opfølgning efter operation for primær cancer mammae

Ugeskrift for Laeger

Volumn 164, Issue 22, 2002, Pages 2918-2922

  Soot, Matte Line ^a   Nielsen, Dorte Lisbeth ^a   Kamby, Claus ^a  

^a Amtssygehuset i Herlev   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST EXAMINATION; CANCER MORTALITY; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; MAMMOGRAPHY; MEDICAL LITERATURE; MINIMAL RESIDUAL DISEASE; MORBIDITY; POSTOPERATIVE PERIOD; QUALITY OF LIFE; REVIEW; BREAST TUMOR; MASTECTOMY; METASTASIS; METHODOLOGY; PSYCHOLOGICAL ASPECT; RADIOGRAPHY; TUMOR RECURRENCE;

BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL;

EID: 0037181979     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. What are the benefits of routine breast cancer follow-up?
2. Is there a need to follow-up cancer patients?
3. Why evidence-based oncology?
4. Follow-up after treatment for breast cancer
5. Cancer risk in close relatives of women with early-onset breast cancer - A population-based incidence study
6. Local recurrence after breast conserving surgery and radiotherapy; frequency, time course, and prognosis
7. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials
8. Significance of ipsilateral breast tumour recurrence after lumpectomy
9. Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow up
10. Survival and pattern of failure following loco-regional recurrence of breast cancer
11. Local-regional recurrence after mastectomy or breast-conserving therapy
12. First isolated locoregional recurrence following mastectomy for breast cancer: Results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation
13. Rutinekontrol af patienter med cancer mammae. Henvisningsmønsterets betydning for overlevelsen efter recidiv
14. Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy
15. Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer
16. Palliative effect of chemotherapy: Objective tumor response is associated with symptom improvement in patients with metastatic breast cancer
17. Long-term sequelae of breast cancer surgery
18. Randomized trial of a psychologic distress screening program after breast cancer: Effects on quality of life
19. Effect of psychosocial treatment on survival of patients with metastatic breast cancer
20. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial
21. Routine follow up of breast cancer in primary care: Randomised trial
22. Effectiveness of routine and spontaneous follow-up visits for breast cancer
23. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines
24. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial
25. Rationaliseringsgevinster inden for billeddiagnostik ved systematisk opfølgningsprogrammer i DBCG's regi. 1
26. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer
27. Routine follow-up of patients after primary therapy for early breast cancer: Changing concepts and challenges for the future
28. Follow-up after treatment of primary breast cancer
29. Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14
30. Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer
31. Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers
32. It is now the age to define the appropriate follow-up of primary breast cancer patients
33. Follow up in breast cancer. A suitable case for reappraisal
34. Screening for recurrent breast cancer-its effectiveness and prognostic value
35. Popularity of less frequent follow up for breast cancer in randomised study: Initial findings from the hotline study
36. A minimalist policy for breast cancer surveillance
37. Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial
38. It is now the age to define the appropriate follow-up of primary breast cancer patients